[{"address1": "171 Oyster Point Boulevard", "address2": "Suite 400", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650 489 9000", "website": "https://www.surrozen.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Surrozen, Inc., a clinical stage biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. The company is developing antibody-based therapeutics which targets various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its products in pipeline include SZN-043, a hepatocyte-specific R-spondin mimetic bispecific fusion protein, which is in Phase 1b clinical trial for the treatment of severe liver diseases, including alcohol-associated hepatitis. The company develops SZN-413, a Fzd4 targeted bi-specific antibody for the treatment of retinal vascular associated diseases. Surrozen, Inc. has collaboration and license agreement with Boehringer Ingelheim International GmbH to research, develop, and commercialize Fzd4 bi-specific antibodies. Surrozen, Inc. is based in South San Francisco, California.", "fullTimeEmployees": 42, "companyOfficers": [{"maxAge": 1, "name": "Mr. Craig C. Parker M.B.A.", "age": 62, "title": "CEO, President & Director", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 825320, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Charles  Williams", "age": 44, "title": "CFO, COO & Corporate Secretary", "yearBorn": 1980, "fiscalYear": 2023, "totalPay": 611028, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Li  Yang Ph.D.", "age": 55, "title": "Executive Vice President of Research", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 535463, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. K. Christopher  Garcia Ph.D.", "title": "Co-Founder & Member of Scientific Advisory Board", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Roeland  Nusse Ph.D.", "age": 74, "title": "Co-Founder & Member of Scientific Advisory Board", "yearBorn": 1950, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Calvin  Kuo M.D., Ph.D.", "title": "Co-Founder & Member of Scientific Advisor", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Esther  Jhun", "title": "Controller", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 11.55, "open": 11.45, "dayLow": 11.38, "dayHigh": 12.25, "regularMarketPreviousClose": 11.55, "regularMarketOpen": 11.45, "regularMarketDayLow": 11.38, "regularMarketDayHigh": 12.25, "payoutRatio": 0.0, "beta": 0.742, "forwardPE": -2.5573034, "volume": 7478, "regularMarketVolume": 7478, "averageVolume": 43483, "averageVolume10days": 24340, "averageDailyVolume10Day": 24340, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 36982724, "fiftyTwoWeekLow": 6.0, "fiftyTwoWeekHigh": 18.17, "priceToSalesTrailing12Months": 3.6982725, "fiftyDayAverage": 11.5219, "twoHundredDayAverage": 10.20777, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 8050167, "profitMargins": 0.0, "floatShares": 1254000, "sharesOutstanding": 3249800, "sharesShort": 138980, "sharesShortPriorMonth": 46415, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.0428, "heldPercentInsiders": 0.0167, "heldPercentInstitutions": 0.78431, "shortRatio": 2.71, "shortPercentOfFloat": 0.0575, "impliedSharesOutstanding": 3249800, "bookValue": 1.744, "priceToBook": 6.5252295, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -44438000, "trailingEps": -16.94, "forwardEps": -4.45, "lastSplitFactor": "1:15", "lastSplitDate": 1702512000, "enterpriseToRevenue": 0.805, "enterpriseToEbitda": -0.321, "52WeekChange": -0.07377708, "SandP52WeekChange": 0.2021538, "quoteType": "EQUITY", "currentPrice": 11.38, "targetHighPrice": 45.0, "targetLowPrice": 32.0, "targetMeanPrice": 38.5, "targetMedianPrice": 38.5, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 2, "totalCash": 31012000, "totalCashPerShare": 9.543, "ebitda": -25060000, "totalDebt": 1527000, "quickRatio": 7.06, "currentRatio": 7.4, "totalRevenue": 10000000, "debtToEquity": 26.945, "revenuePerShare": 3.804, "returnOnAssets": -0.32645, "returnOnEquity": -1.73593, "grossProfits": -11877000, "freeCashflow": -19690376, "operatingCashflow": -28420000, "grossMargins": -1.1876999, "ebitdaMargins": -2.506, "operatingMargins": 0.1232, "financialCurrency": "USD", "symbol": "SRZN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "regularMarketTime": 1740169978, "exchange": "NCM", "messageBoardId": "finmb_401948183", "shortName": "Surrozen, Inc.", "longName": "Surrozen, Inc.", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.4718621, "regularMarketPrice": 11.38, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1610375400000, "regularMarketChange": -0.17000008, "regularMarketDayRange": "11.38 - 12.25", "fullExchangeName": "NasdaqCM", "marketState": "REGULAR", "averageDailyVolume3Month": 43483, "fiftyTwoWeekLowChange": 5.38, "fiftyTwoWeekLowChangePercent": 0.8966667, "fiftyTwoWeekRange": "6.0 - 18.17", "fiftyTwoWeekHighChange": -6.79, "fiftyTwoWeekHighChangePercent": -0.3736929, "fiftyTwoWeekChangePercent": -7.377708, "earningsTimestampStart": 1730927109, "earningsTimestampEnd": 1730927109, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -16.94, "epsForward": -4.45, "epsCurrentYear": -14.94, "priceEpsCurrentYear": -0.76171356, "fiftyDayAverageChange": -0.14190006, "fiftyDayAverageChangePercent": -0.012315682, "twoHundredDayAverageChange": 1.1722298, "twoHundredDayAverageChangePercent": 0.114837006, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-08-12", "prevName": "Consonance-HFW Acquisition Corp.", "nameChangeDate": "2025-02-21", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "displayName": "Surrozen", "trailingPegRatio": null, "__fetch_time": "2025-02-21"}]